RP

Revathi Parvatham

Director Director DIN 08819218
DIN 08819218 First appointment Aug 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2020
Shareholding value Locked Premium profile

About Revathi Parvatham

Revathi Parvatham has 5 years in corporate governance. Formerly with 1 company, such as Neovel Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08819218
Primary Designation Director
First Appointment 02 Aug 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Neovel Pharma Private Limited U51909TG2020PTC142418
Director 02 Aug 2020 2020 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neovel Pharma Private Limited
Premium access

Shareholding and investment profile for Revathi Parvatham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Revathi Parvatham

Revathi Parvatham has 5 years in corporate governance. Formerly with 1 company, such as Neovel Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Revathi Parvatham is associated with 0 companies as a director.

Revathi Parvatham has expertise in General Business.

Revathi Parvatham has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available